PROF. DR. ELIF ÇADIRCI'S CONTRIBUTION TO SCIENCE WAS AWARDED
Turkey Scientific and Technological Research Council of Turkey (TUBITAK) "TUBITAK's Science, Private, Service and Incentive Awards" sssessment works were finished, which are given to support research and development activities in scientific and technological areas and to to provide the opportunity for educating and developing researchers.
In this direction, Atatürk University Faculty of Medicine Faculty Member Prof. Dr. Elif Çadırcı received the Incentive Award for her “internationally outstanding work on the effects of new receptors in the treatment of new diseases, new indications of existing agents and elucidation mechanisms in many studies that can contribute to the science of pharmacology and the basic field of health sciences”.
Prof. Dr. Elif Çadırcı said “I would like to express that I am very happy to receive TÜBİTAK Incentive Award, which is the most prestigious science award of our country, and to see my work is appreciated. I would like to thank My family, who believed in me and supported me throughout my academic life, and my colleagues and our rector Prof. Dr. Ömer Çomaklı."
Atatürk University Rector Prof. Dr. Ömer Çomaklı congratulated Faculty of Medicine Faculty Member Prof. Dr. Elif Çadırcı for her studies, researches and the incentive award she received as a result and wished her continued success.
TÜBİTAK Incentive Award and Prof. Dr. Elif Çadırcı
TUBITAK Incentive Award is given to the resident scientists who have prove to significantly contribute to science for his work internationally in the future and have not passed the age of 40 on the first day of the year in which the award is given.
Prof. Dr. Elif Çadırcı works in the fields of Serotonin 5-HT7 and UTR2 Receptors and their Physiopathological Role, Sepsis, Sepsis Physiopathology and New Treatment Strategies, Inflammation and related Diseases, Gastric Ulcer, Boron Mine and Usage in Bone Health. 126 articles published in journals covered by SCI were cited 1735 times and H-index is 23.
CORPORATE COMMUNICATION DIRECTORATE - 12.11.2020